Concepedia

CYP2B6 Genotype Alters Abstinence Rates in a Bupropion Smoking Cessation Trial

Anna Lee, Christopher Jepson, Ewa Hoffmann, Leonard H. Epstein, Larry W. Hawk, Caryn Lerman, Rachel F. Tyndale

Biological Psychiatry · 2007 · 131 citations · 40 references

DOI

Concepts

References

40

Biochemical verification of tobacco use and cessation

Neal L. Benowitz, Peyton Jacob, Karen Ahijevych et al. · Nicotine & Tobacco Research · 2002 · 1.8K citations · Full text

, , +11

Efficacy of Varenicline, an α4β2 Nicotinic Acetylcholine Receptor Partial Agonist, vs Placebo or Sustained-Release Bupropion for Smoking Cessation<SUBTITLE>A Randomized Controlled Trial</SUBTITLE>

Douglas E. Jorenby · JAMA · 2006 · 1.7K citations

, , +17

A Controlled Trial of Sustained-Release Bupropion, a Nicotine Patch, or Both for Smoking Cessation

Douglas E. Jorenby, Scott J. Leischow, Mitchell Nides et al. · New England Journal of Medicine · 1999 · 1.6K citations · Full text

, , +16

Varenicline, an α4β2 Nicotinic Acetylcholine Receptor Partial Agonist, vs Sustained-Release Bupropion and Placebo for Smoking Cessation<SUBTITLE>A Randomized Controlled Trial</SUBTITLE>

David Gonzales · JAMA · 2006 · 1.4K citations

, , +17

A Comparison of Sustained-Release Bupropion and Placebo for Smoking Cessation

R. Douglas Hurt, David P.L. Sachs, Elbert D. Glover et al. · New England Journal of Medicine · 1997 · 1.3K citations

, , +14